throbber

`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`ARGENTUM PHARMACEUTICALS LLC
`
`Petitioner
`
`v.
`
`CIPLA LIMITED
`
`Patent Owner
`
`_____________________
`
`Case No. IPR2017-00807
`
`U.S. Patent No. 8,168,620
`_____________________
`
`JOINT MOTION TO TERMINATE PROCEEDINGS
`PURSUANT TO 35 U.S.C. § 317
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`

`

`
`
`
`
`
`
`
`IPR2017-00807
`Joint Motion to Terminate
`
`As authorized in the Patent Trial and Appeal Board’s e-mail dated May 16,
`
`2018, and pursuant to 35 U.S.C. § 317(a) and 37 C.F.R. §§ 42.72 and 42.74, Patent
`
`Owner and Petitioner jointly and respectfully request that the inter partes review
`
`(“IPR”) of U.S. Patent No. 8,168,620 be terminated.
`
`I.
`
`Statement of Relief Requested
`
`Pursuant to 35 U.S.C. § 317, 37 C.F.R. § 42.72, and 37 C.F.R. § 42.74, and
`
`pursuant to the authorization to file this motion provided by the Board with the
`
`parties on May 16, 2018, Petitioner Argentum Pharmaceuticals LLC (“Argentum”)
`
`and Patent Owner Cipla Limited (“Cipla”) jointly request the termination of this
`
`inter partes review of U.S. Patent No. 8,168,620 in its entirety as a result of
`
`settlement between Petitioner and Patent Owner.
`
`The parties have settled their dispute and executed a settlement agreement to
`
`terminate this inter partes review.
`
`The parties’ settlement agreement has been made in writing, and a true and
`
`correct copy is being filed concurrently herewith as Exhibit 2183. The parties are
`
`also filing concurrently herewith a joint request to treat the settlement agreement as
`
`business confidential information and keep it separate from the files of the IPR and
`
`the involved patent pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(b) and
`
`(c).
`
`
`
`- 1 -
`
`

`

`
`
`
`II.
`
`Statement of Facts
`
`
`
`
`IPR2017-00807
`Joint Motion to Terminate
`
`Petitioner filed this IPR petition on February 2, 2017. On August 21, 2017,
`
`the Board instituted inter partes review of claims 1, 4-6, 24-26, 29, and 42-44 of
`
`the ’620 patent. On May 15, 2018, Petitioner and Patent Owner entered into a
`
`settlement agreement. See CIP2183 (Confidential). Argentum agrees to terminate
`
`this IPR proceeding.
`
`The Board has not yet decided the merits of the pending IPR proceeding.
`
`III. Argument
`35 U.S.C. § 317(a) provides: “An inter partes review instituted under this
`
`chapter shall be terminated with respect to any petitioner upon the joint request of
`
`the petitioner and the patent owner, unless the Office has decided the merits of the
`
`proceeding before the request for termination is filed.” 35 U.S.C. § 317(a).
`
`Similarly, 37 C.F.R. § 42.72 provides that “[t]he Board may terminate a trial
`
`without rendering a final written decision, where appropriate, including where the
`
`trial is consolidated with another proceeding or pursuant to a joint request under 35
`
`U.S.C. 317(a).”
`
`The Trial Practice Guide additionally counsels that “[t]here are strong public
`
`policy reasons to favor settlement between the parties to proceeding” and that the
`
`Board “expects that a proceeding will terminate after the filing of a settlement
`
`agreement, unless the Board has already decided the merits of the proceeding. 35
`
`
`
`- 2 -
`
`

`

`
`
`
`U.S.C. 317(a), as amended, and 35 U.S.C. 327.” Office Patent Trial Practice
`
`IPR2017-00807
`Joint Motion to Terminate
`
`
`
`
`Guide, 77 Fed. Reg. 48,756, 48,768 (Aug. 14, 2012).
`
`A.
`
` Termination of this proceeding is proper.
`
`As noted in the Statement of Facts, oral argument has not yet occurred.
`
`Thus, the Board has not yet “decided the merits of the proceeding before the
`
`request for termination is filed.” 35 U.S.C. § 317(a); 77 Fed. Reg. 48768 (“The
`
`Board expects that a proceeding will terminate after the filing of a settlement
`
`agreement, unless the Board has already decided the merits of the proceeding.”).
`
`The Board has already cancelled the oral hearing that was scheduled to take place
`
`in this proceeding. Further, the parties are unaware of any other matter before the
`
`Board that would be affected by the outcome of this proceeding. Accordingly, the
`
`parties respectfully request that the Board terminate the inter partes review of U.S.
`
`Patent No. 8,168,620.
`
`In the past, the Board has terminated the entire proceedings based on joint
`
`motions to terminate even after the merits had been fully briefed and the matter
`
`was ready for oral argument, or even after oral argument. See Toyota Motor Corp.
`
`v. Blitzsafe Tex. LLC, IPR2016-00421, Paper 28 (Feb. 21, 2017) (granting motion
`
`to terminate even after all substantive papers were filed, “particularly in light of the
`
`fact that a final written decision is not due until more than four months from
`
`now”); Plaid Techs., Inc. v. Yodlee, Inc., IPR2016-00273, Paper 29 (Feb. 8, 2017)
`
`
`
`- 3 -
`
`

`

`
`
`
`(granting motion to terminate because “the parties’ joint motions to terminate were
`
`IPR2017-00807
`Joint Motion to Terminate
`
`
`
`
`filed prior to the oral hearings in these cases”); Apex v. Resmed, IPR2013-00512,
`
`Paper 39 (Sept. 12, 2014) (granting joint motion to terminate after the parties had
`
`fully briefed the matter); Rackspace Hosting, Inc. v. Clouding IP, LLC, CBM2014-
`
`00034, Paper 28 (Dec. 9, 2014) (granting motion to terminate after close of
`
`evidentiary record and less than ten days before trial); Volution v. Versata
`
`Software, CBM2013-00018, Paper 52 (June 17, 2014) (granting motion to
`
`terminate after oral argument).
`
`Further, because the Board has yet to conduct an oral hearing and issue a
`
`decision on the merits, termination of the entire proceeding would save the Board
`
`significant administrative resources. Termination would also further AIA’s purpose
`
`of providing an efficient and less costly alternative forum for patent disputes and
`
`its encouragement for settlement.
`
`IV. Related Litigations Involving The Patent At Issue
`Litigations involving the patent at issue in this proceeding are set forth
`
`below. As shown below, none of these litigations is currently pending as each has
`
`been resolved.
`
`Case
`Meda Pharmaceuticals Inc. et al v. Apotex
`Inc. et al., 14-1453-LPS (D. Del.) (filed Dec.
`2, 2014; settled May 17, 2017)
`
`Defendant(s)
`Apotex Inc.
`Apotex Corp.
`
`
`
`- 4 -
`
`

`

`
`
`
`IPR2017-00807
`Joint Motion to Terminate
`
`
`
`
`Meda Pharmaceuticals Inc. et al v. Teva
`Pharmaceuticals USA, Inc., 15-785-LPS (D.
`Del.) (filed Sept. 8, 2015; settled July 28,
`2017)
`Meda Pharmaceuticals Inc. et al v. Perrigo
`UK FINCO Limited Partnership et al., 16-
`794 (D. Del.) (filed Sept. 9, 2016; settled July
`7, 2017)
`
`V. Related Inter Partes Review Proceedings Currently Before The Office
`There are no other inter partes review proceedings currently before the
`
`Teva Pharmaceuticals USA,
`Inc.
`
`
`Perrigo UK FINCO Limited
`Partnership; Perrigo Company;
`Perrigo Pharmaceuticals Co.
`
`Office involving the patent at issue.
`
`VI. Written Settlement Statement
`Pursuant to 37 C.F.R. § 42.74(c), the parties are filing herewith as CIP2183
`
`a true copy of the settlement agreement entered between the parties on May 16,
`
`2018. The settlement agreement was entered into in contemplation of termination
`
`of this proceeding.
`
`Petitioner and Patent Owner respectfully request that the Board grant the
`
`parties’ Joint Motion to Terminate this proceeding in its entirety and grant the
`
`request to treat the settlement agreement between the parties as business
`
`confidential information.
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`/Michael Houston/
`
`- 5 -
`
`

`

`
`
`
`Date: May 17, 2018
`
`
`
`
`Date: May 17, 2018
`
`
`
`
`
`
`
`
`
`IPR2017-00807
`Joint Motion to Terminate
`
`Michael R. Houston
`Reg. No. 58,486
`Lead Attorney for Petitioner
`
`
`Respectfully submitted,
`
`
`/Dennies Varughese/
`Dennies Varughese
`Registration No. 61,868
`Lead Attorney for Patent Owner
`
`
`
`
`
`- 6 -
`
`

`

`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies
`
`that
`
`the above-captioned “JOINT
`
`MOTION TO TERMINATE PROCEEDINGS PURSUANT TO 35 U.S.C. § 317”
`
`was served in its entirety on May 17, 2018, upon the following parties via
`
`electronic mail upon the following counsel of record for the Petitioner:
`
`Michael R. Houston: mhouston@foley.com
`Joseph P. Meara: jmeara@foley.com
`James P. McParland: jmcparland@foley.com
`Tyler C. Liu: TLiu@agpharm@foley.com
`ARG-dymista@foley.com
`
`FOLEY & LARDNER LLP
`321 North Clark Street
`Suite 2800
`Chicago, IL 60654
`
`
`
`
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`Dennies Varughese
`Registration No. 61,868
`Lead Attorney for Patent Owner
`
`
`
`
`Date: May 17, 2018
`1100 New York Avenue, N.W.
`Washington, D.C. 20005
`(202) 371-2600
`
`9355960.1
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket